Resuscitation
Volume 66, Issue 2 , Pages 183-188 , August 2005

Quality of life of elderly patients after prehospital thrombolytic therapy

  • Olli Väisänen

      Affiliations

    • Arcada Polytechnic, Helsinki, Jan-Magnus Janssonin aukio 1, 00550 Helsinki, Finland
    • Helinki Area Helicopter Emergency Medical Service, Finland
    • Department of Anaesthesiology and Intensive Care Medicine, Helsinki University Hospital, Finland
    • Corresponding Author InformationCorresponding author. Tel.: +358 50 330 82 77; fax: +358 207 699556.
    • ,
  • Markku Mäkijärvi

      Affiliations

    • Department of Medicine, Division of Cardiology and Biomag Laboratory, Helsinki University Hospital, Finland
    • ,
  • Tom Silfvast

      Affiliations

    • Helinki Area Helicopter Emergency Medical Service, Finland
    • Department of Anaesthesiology and Intensive Care Medicine, Helsinki University Hospital, Finland

Received 30 September 2004 ,Revised 8 February 2005 ,Accepted 28 February 2005.

References 

  1. Barakat K, Wilkinson P, Deaner A, Fluck D, Ranjadayalan K, Timmis A. How should age affect management of acute myocardial infarction? A prospective cohort study. Lancet. 1999;353:955–959
  2. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 1993;329:1615–1622
  3. Simoons ML, Maggioni AP, Knatterud G, et al. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet. 1993;342:1523–1528
  4. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996;348:771–775
  5. The European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med. 1993;329:383–389
  6. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. J Am Med Assoc. 2000;283:2686–2692
  7. Gollub SB. Is intensive drug therapy appropriate for older patients?. Lancet. 1999;353:940–941
  8. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1:480–484
  9. Mahoney FI, Barthel DW. Functional Evaluation: the Barthel Index. Md State Med J. 1965;14:61–65
  10. The Criteria Committee of the New York Heart Association Inc. Kossman CE (chairman). Diseases of the heart and blood vessels: nomenclature and criteria for diagnosis, Boston: Little Brown, 1964.
  11. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571
  12. Stason WB, Sanders CA, Smith HC. Cardiovascular care of the elderly: economic considerations. J Am Coll Cardiol. 1987;10:18A–21A
  13. Castaigne AD, Herve C, Duval-Moulin AM, et al. Prehospital use of APSAC: results of a placebo-controlled study. Am J Cardiol. 1989;64:30A–33A[discussion 41A–42A]
  14. Roth A, Barbash GI, Hod H, et al. Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. J Am Coll Cardiol. 1990;15:932–936
  15. Schofer J, Buttner J, Geng G, et al. Prehospital thrombolysis in acute myocardial infarction. Am J Cardiol. 1990;66:1429–1433
  16. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. J Am Med Assoc. 1993;270:1211–1216
  17. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397–402
  18. White HD, Barbash GI, Califf RM, et al. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation. 1996;94:1826–1833
  19. Second International Study of Infarct Survival (ISIS-2) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349–360
  20. Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med. 2000;160:1818–1823
  21. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation. 1995;91:999–1005
  22. Steeds RP, Bickerton D, Smith MJ, Muthusamy R. Assessment of depression following acute myocardial infarction using the Beck depression inventory. Heart. 2004;90:217–218
  23. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311–322
  24. GREAT Group. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. Br Med J. 1992;305:548–553
  25. Brouwer MA, Martin JS, Maynard C, et al. Influence of early prehospital thrombolysis on mortality and event-free survival (the Myocardial Infarction Triage and Intervention [MITI] Randomized Trial). MITI Project Investigators. Am J Cardiol. 1996;78:497–502
  26. Califf RM, Pieper KS, Lee KL, et al. Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation. 2000;101:2231–2238
  27. Hakkinen U, Idanpaa-Heikkila U, Keskimaki I, Rauhala A, Klaukka T, Teitto E. Akuutin sydaninfarktin hoitokaytantojen, kustannusten ja vaikuttavuuden vertailu. STAKES. 2002;9
  28. Hirvonen TP, Halinen MO, Kala RA, Olkinuora JT. Delays in thrombolytic therapy for acute myocardial infarction in Finland. Results of a national thrombolytic therapy delay study. Finnish Hospitals’ Thrombolysis Survey Group. Eur Heart J. 1998;19:885–892

☆ A Spanish translated version of the Abstract and Keywords of this article appears as Appendix at 10.1016/j.resuscitation.2005.02.012.

PII: S0300-9572(05)00154-1

doi: 10.1016/j.resuscitation.2005.02.012

Resuscitation
Volume 66, Issue 2 , Pages 183-188 , August 2005

Article Tools